Skip to content

AptarGroup ATR Gross Profit

Gross Profit at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$296.4M+27.8%
Amcor logo
AmcorAMCR
$1.19B+82.0%
Baxter International logo
Baxter InternationalBAX
$891M+3.5%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$482.22M+42.5%
Nordson logo
NordsonNDSN
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's gross profit?
AptarGroup (ATR) reported gross profit of $351.91M in Q1 2026.
How has AptarGroup's gross profit changed year-over-year?
AptarGroup's gross profit increased by 4.6% year-over-year, from $336.41M to $351.91M.
What is the long-term trend for AptarGroup's gross profit?
Over 2 years (2023 to 2025), AptarGroup's gross profit has grown at a 5.4% compound annual growth rate (CAGR), from $1.26B to $1.4B.